In the Media


Back to All Media

Dec 18, 2017

AquaBounty on the verge of a major growth spurt as they transition from R&D to operations

Ronald Stotish, president and chief executive of AquaBounty Technologies (NASDAQ:AQB), tells Proactive they're a small biotechnology company that was founded roughly 20 years ago with the strategic intent to apply the tools of modern molecular biology and molecular genetics to aquaculture. ''We believe that aquaculture is one of the ways to meet future quality protein needs in a sustainable and environmentally-friendly way and we believe there are tremendous opportunities by applying modern molecular biology and molecular genetics to improve productivity and the efficiency of production of seafood''. ''We know we have a good product, our experience to date has been  good and at the moment we've achieved something that no-one else has done''. ''We're pioneers in this area and we believe that we're about to enter into a business that will help meet global food security needs for the next 50 years''.  Read and listen to interview.

More Recent Updates